Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion type Assertion NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_head.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_provenance.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion evidence source_evidence_literature NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_provenance.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion SIO_000772 16232198 NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_provenance.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion wasDerivedFrom befree-20150227 NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_provenance.
- NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_assertion wasGeneratedBy ECO_0000203 NP677667.RA2EM8gjM5GUIJuvxWyrbeveqowjRUAigIjbJrtgL_KEE130_provenance.